Merit Medical Systems Shares Outstanding 2010-2024 | MMSI

Merit Medical Systems shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merit Medical Systems shares outstanding for the quarter ending March 31, 2024 were 0.059B, a 0.66% increase year-over-year.
  • Merit Medical Systems 2023 shares outstanding were 0.058B, a 1.19% increase from 2022.
  • Merit Medical Systems 2022 shares outstanding were 0.058B, a 0.54% increase from 2021.
  • Merit Medical Systems 2021 shares outstanding were 0.057B, a 3.47% increase from 2020.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2023 58
2022 58
2021 57
2020 55
2019 56
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
2010 36
2009 36
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 59
2023-12-31 58
2023-09-30 58
2023-06-30 58
2023-03-31 58
2022-12-31 58
2022-09-30 58
2022-06-30 58
2022-03-31 58
2021-12-31 57
2021-09-30 58
2021-06-30 57
2021-03-31 57
2020-12-31 55
2020-09-30 56
2020-06-30 55
2020-03-31 55
2019-12-31 56
2019-09-30 55
2019-06-30 57
2019-03-31 56
2018-12-31 54
2018-09-30 55
2018-06-30 52
2018-03-31 52
2017-12-31 50
2017-09-30 52
2017-06-30 51
2017-03-31 46
2016-12-31 45
2016-09-30 45
2016-06-30 45
2016-03-31 45
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 44
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 43
2013-09-30 43
2013-06-30 43
2013-03-31 43
2012-12-31 43
2012-09-30 43
2012-06-30 42
2012-03-31 42
2011-12-31 40
2011-09-30 43
2011-06-30 38
2011-03-31 36
2010-12-31 36
2010-09-30 35
2010-06-30 36
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.034B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.631B 21.23
Becton Dickinson (BDX) United States $67.642B 19.14
West Pharmaceutical Services (WST) United States $23.823B 42.69
Cardinal Health (CAH) United States $23.375B 13.37
Align Technology (ALGN) United States $18.864B 36.42
Labcorp (LH) United States $18.190B 15.66
Cooper (COO) United States $18.112B 26.71
Henry Schein (HSIC) United States $9.120B 16.22
DENTSPLY SIRONA (XRAY) United States $5.718B 14.81
Patterson (PDCO) United States $2.315B 11.42
CONMED (CNMD) United States $2.267B 20.56
STAAR Surgical (STAA) United States $2.173B 83.45
Atrion (ATRI) United States $0.803B 42.90
Lifevantage (LFVN) United States $0.081B 10.51
Pro-Dex (PDEX) United States $0.068B 34.31